| 1 |
20127950 | Toxicity and efficacy of combined radioimmunotherapy and bevacizumab in a mouse model of medullary thyroid carcinoma. | 2010 Feb 15 |
1 |
| 2 |
19140107 | Concordant activity of transgene expression cassettes inserted into E1, E3 and E4 cloning sites in the adenovirus genome. | 2009 Mar |
2 |
| 3 |
18682714 | Fractionated 131I anti-CEA radioimmunotherapy: effects on xenograft tumour growth and haematological toxicity in mice. | 2008 Aug 19 |
1 |
| 4 |
11435076 | Enhancement of the therapeutic outcome of radio-immunotherapy by combination with whole-body mild hyperthermia. | 2001 Jul |
2 |
| 5 |
10716323 | Pretargeted radioimmunotherapy of human colorectal xenografts with bispecific antibody and 131I-labeled bivalent hapten. | 2000 Mar |
1 |
| 6 |
10911919 | Radioimmunotherapy of colorectal cancer liver metastases: combination with radiotherapy. | 2000 Jun |
1 |
| 7 |
11775212 | Fractionated radioimmunotherapy using low doses of iodine-131 labeled anti-CEA monoclonal antibody after tumor volume reduction. | 2000 Jan |
1 |
| 8 |
10210230 | Intratumoral distribution of radiolabeled antibody and radioimmunotherapy in experimental liver metastases model of nude mouse. | 1999 Apr |
1 |
| 9 |
10359050 | Radioimmunotherapy for liver micrometastases in mice: pharmacokinetics, dose estimation, and long-term effect. | 1999 Mar |
1 |
| 10 |
10505044 | Chronotolerance of experimental radioimmunotherapy: clearance, toxicity, and maximal tolerated dose of 131I-anti-carcinoembryonic antigen (CEA) IgG as a function of time of day of dosing in a murine model. | 1999 May |
1 |
| 11 |
9025751 | Regression of advanced refractory ovarian cancer treated with iodine-131-labeled anti-CEA monoclonal antibody. | 1997 Feb |
1 |
| 12 |
9393755 | Improved treatment of medullary thyroid cancer in a nude mouse model by combined radioimmunochemotherapy: doxorubicin potentiates the therapeutic efficacy of radiolabeled antibodies in a radioresistant tumor type. | 1997 Dec 1 |
2 |
| 13 |
8491228 | Uptake of radiolabeled anti-CEA antibodies in human colorectal primary tumors as a function of tumor mass. | 1993 Apr |
1 |
| 14 |
1536812 | Haematological effects of radioimmunotherapy in cancer patients. | 1992 Jan |
1 |
| 15 |
1735611 | Different behaviour of mouse-human chimeric antibody F(ab')2 fragments of IgG1, IgG2 and IgG4 sub-class in vivo. | 1992 Feb 1 |
1 |
| 16 |
2691716 | [Experimental study of tumor detection using 131I-labeled F (ab)2 fragments of monoclonal antibodies to CA 19-9 and CEA (IMACIS-1)]. | 1989 Dec |
1 |
| 17 |
2708519 | Ablation of human colon carcinoma in nude mice by 131I-labeled monoclonal anti-carcinoembryonic antigen antibody F(ab')2 fragments. | 1989 May |
1 |
| 18 |
3464424 | Comparative imaging and biodistribution studies with an anti-CEA monoclonal antibody and its F(ab)2 and Fab fragments in mice with colon carcinoma xenografts. | 1986 |
1 |